Skip to main content

Ion Channel Disease

  • Chapter
  • First Online:
  • 826 Accesses

Abstract

Ion channel diseases are diseases caused by dysfunction of ion channel subunits or the regular proteins. Ion channels are essential in neuronal signaling and thus channelopathies can be found in skeletal muscle or central nervous system diseases, which include hyperkalemic and hypokalemic periodic paralysis, episodic ataxia, familial hemiplegic migraine, generalized epilepsy with febrile seizures plus and so on. These diseases can be either acquired or inherited. Since 1990, many mutations in genes encoding ion channel components have been discovered to cause disorders. The findings of genetic causes contribute to explain similarities and differences in clinical and laboratory manifestations in these disorders. In this chapter, we presented two commonly encountered ion channel diseases caused by genetic mutations.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Abbas H, Kothari N, Bogra J. Hypokalemic periodic paralysis. Natl J Maxillofac Surg. 2012;3(2):220–1.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Santra G, De D, Sinha PK. Hypokalemic periodic paralysis due to proximal renal tubular acidosis in a case with membranoproliferative glomerulonephritis. J Assoc Physicians India. 2011;59:735–7.

    PubMed  Google Scholar 

  3. Wang XY, Ren BW, Yong ZH, Xu HY, Fu QX, Yao HB. Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. Mol Med Rep. 2015;12(4):6267–74.

    CAS  PubMed  Google Scholar 

  4. Burge JA, Hanna MG. Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep. 2012;12(1):62–9.

    Article  CAS  PubMed  Google Scholar 

  5. Kim H, Hwang H, Cheong HI, Park HW. Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations. Korean J Pediatr. 2011;54(11):473–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sansone VA, Burge J, McDermott MP, Smith PC, Herr B, Tawil R, Pandya S, Kissel J, Ciafaloni E, Shieh P, Ralph JW, Amato A, Cannon SC, Trivedi J, Barohn R, Crum B, Mitsumoto H, Pestronk A, Meola G, Conwit R, Hanna MG, Griggs RC, Muscle Study G. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86(15):1408–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Greig SL. Dichlorphenamide: a review in primary periodic paralyses. Drugs. 2016;76(4):501–7.

    Article  CAS  PubMed  Google Scholar 

  8. Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, Tristani-Firouzi M, Tawil R, Griggs RC, investigators C. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006;129(Pt 1):8–17.

    CAS  PubMed  Google Scholar 

  9. Vicart S, Sternberg D, Fournier E, Ochsner F, Laforet P, Kuntzer T, Eymard B, Hainque B, Fontaine B. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology. 2004;63(11):2120–7.

    Article  CAS  PubMed  Google Scholar 

  10. Miller TM, da Silva MRD, Miller HA, Kwiecinski H, Mendell JR, Tawil R, McManis P, Griggs RC, Angelini C, Servidei S, Petajan J, Dalakas MC, Ranum LP, Fu YH, Ptacek LJ. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004;63(9):1647–55.

    Article  CAS  PubMed  Google Scholar 

  11. Corrochano S, Mannikko R, Joyce PI, McGoldrick P, Wettstein J, Lassi G, Raja Rayan DL, Blanco G, Quinn C, Liavas A, Lionikas A, Amior N, Dick J, Healy EG, Stewart M, Carter S, Hutchinson M, Bentley L, Fratta P, Cortese A, Cox R, Brown SD, Tucci V, Wackerhage H, Amato AA, Greensmith L, Koltzenburg M, Hanna MG, Acevedo-Arozena A. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis. Brain. 2014;137(Pt 12):3171–85.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lehmann-Horn F, Jurkat-Rott K, Rudel R, Ulm Muscle C. Diagnostics and therapy of muscle channelopathies—Guidelines of the Ulm Muscle Centre. Acta Myol. 2008;27:98–113.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu Lin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Lin, Y. (2017). Ion Channel Disease. In: Wu, ZY. (eds) Inherited Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-10-4196-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4196-9_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4195-2

  • Online ISBN: 978-981-10-4196-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics